Articles > Insulins & Non-insulins

  1. Project Pizza: A Slice of T1D Research with GluAlex

    Has there ever been a food more beloved and yet more challenging for people with type 1 diabetes? Something about that high carb/high fat mix makes pizza both incredibly delicious and incredibly difficult to control blood sugar! Here at Glu, GluAlex attempted to find the right pizza bolus. Here’s what he learned: Project Pizza Night […]

    Read More
  1. Join Glu in Central Massachusetts for Family Diabetes Day!

    Diabetes Day Mailer cropped

    Central Mass folks-come join us at the Family Diabetes Day! Glu is co-hosting this program with the American Diabetes Association to bring you a day of fun for all ages. We’ll have age-appropriate break outs for kids, teens, parents, and adults with type 1 as well as panel discussions and research updates including the Bionic […]

    Read More
  2. SGLT-2 Inhibitors Associated with DKA in Type 1 Patients, Warnings Now Required

    Close-up looking over a woman's shoulder to her holding a bottle of prescription medication

    The FDA recently mandated that users of SGLT-2 inhibitor drugs be warned of the risks of diabetic ketoacidosis (DKA) after receiving more than 70 reports of DKA. The agency previously issued a safety statement regarding these drugs’ potential dangerous side effects. SGLT-2 inhibitors, such as empagliflozin (Jardiance), dapagliflozin (Farxiga), and canagliflozin (Invokana), are a promising […]

    Read More
  3. Did you know? Steroid Medications Known to Increase Insulin Requirements

    Vials of Pills

    Type 1 diabetes (T1D) care, and particularly glycemic control, does not exist in a vacuum. Even if someone with T1D were to eat the exact same diet every day, his or her insulin requirements could still change. Exercise, stress, and environmental factors can have huge impacts on blood sugar (BG) management. And, environmental factors can […]

    Read More
  1. New Film Explains Monogenic Diabetes

    cover photo plain600

    An intriguing film was shown at this year’s ADA Scientific Sessions in Boston. Journey of a Miracle: Freedom from Insulin tells the story of several families who had children who were diagnosed with type 1 diabetes, but actually had monogenic diabetes. Dr. Louis Philipson of the University of Chicago introduced the film to the standing-room-only […]

    Read More
  2. FDA Issues Safety Statement that SGLT-2 Inhibitors May Cause Diabetic Ketoacidosis

    Anne Peters MD

    [Editor’s note: several months ago, we ran an article after Dr. Anne Peters of the University of Southern California reported some patients who took SGLT-2 inhibitors like Invokana off-label experienced diabetic ketoacidosis (DKA) while ill and even having evidently normal blood glucose levels. Our friends at diaTribe have posted an update after the FDA recently […]

    Read More
  3. Glu Event Recap & Podcast: Examining Insulins of Today and Tomorrow

    combo bolus

    This event was recorded and is available to stream or download here. Cover the carbs, correct highs, treat lows and don’t correct in under three hours from the last bolus. That, in a nutshell, is what my husband and I have been doing for our son Miles for the past year and a half. Perhaps […]

    Read More
  4. Giving to Glu: A Supporter’s Story

    old needle

    Why support Glu? What’s in it for you? I have had type 1 diabetes for almost 47 years now. My family of eight was visiting relatives in the eighth month of 1968, when, at the age of 8, my life changed forever. I was taken to a small hospital in Lynchburg, Virginia, admitted with a […]

    Read More
  5. Back to the Future: Examining Insulins of Today and Tomorrow

    Insulin Collage

    As we prepare for our next Glu community event on March 31, it made me stop and think long and hard about what insulin actually is and does. When was the last time you were trained on the timing and duration of insulin? What do you wish you knew about the types of insulin, or […]

    Read More
  6. T1D Exchange Presents Data on New Form of Glucagon “Rescue” Treatment for Severe Hypoglycemia

    JennChristensenHOD_281

    A new approach to emergency glucagon delivery for the treatment of diabetes-related severe hypoglycemia was recently presented by T1D Exchange at the Advanced Technologies & Treatments for Diabetes (ATTD) international conference in Paris, France. Researchers also presented data that sheds light on those individuals most at risk for complications, with type 1 diabetes perhaps most at […]

    Read More